Journal of Clinical Oncology (JCO) Podcast
By American Society of Clinical Oncology (ASCO)
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 90
Reviews: 0
Episodes: 399
Description
The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results published in ASCO’s Journal of Clinical Oncology.
| Episode | Date |
|---|---|
|
Commonly Held Beliefs About Cancer Survivorship
|
Apr 11, 2024 |
|
JCO Article Insights: Long Term Follow Up of the RESORT (E4402) and LYSA Study
|
Mar 25, 2024 |
|
Pembrolizumab in Patients With Advanced Cancers With HTMB
|
Mar 14, 2024 |
|
JCO Article Insights: Axillary Soft Tissue Involvement and Breast Cancer Prognosis
|
Feb 26, 2024 |
|
Omission of Radiotherapy after Breast-Conserving Surgery
|
Feb 22, 2024 |
|
Costs of Cancer Prevention in CDH1 Variant Carriers
|
Feb 08, 2024 |
|
JCO Article Insights: Low and Moderate Grade Adverse Events and the Patient Experience in Clinical Trials
|
Jan 29, 2024 |
|
Debunking Sex and Disentangling Gender From Oncology
|
Jan 25, 2024 |
|
Germline EGFR Mutations and Familial Lung Cancer
|
Jan 11, 2024 |
|
JCO Article Insights: DYPD-Guided Dose Individualization and Survival Outcomes
|
Jan 04, 2024 |
|
Negative Impact of Prior Authorization on Patients with Cancer
|
Dec 14, 2023 |
|
Role of Molecular Classification in Predicting Response to Radiation in Early Endometrial Cancer
|
Nov 30, 2023 |
|
JCO Article Insights: Impact of Physical Activity on Mortality and of BMI on Treatment-Related Adverse Events
|
Nov 27, 2023 |
|
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial
|
Nov 05, 2023 |
|
JCO Article Insights: Safety and efficacy of a Novel ADC Targeting TROP-2 in Metastatic Non-Small Cell Lung Cancer (NSCLC)
|
Oct 30, 2023 |
|
Economic Evaluation of a Non-Medical Financial Assistance Program on Missed Treatment Appointments Among Adults With Cancer
|
Oct 28, 2023 |
|
Disparities in End-of-Life Cancer Care
|
Oct 12, 2023 |
|
Advance Care Planning in Adolescents and Young Adults with Cancer
|
Sep 28, 2023 |
|
JCO Article Insights: Improving Lung Cancer Screening Using Blood-Based Biomarkers
|
Sep 25, 2023 |
|
Impact of Smoking Cessation on Mortality From Kidney Cancer
|
Sep 14, 2023 |
|
HER3-DXd in EGFR-Mutated NSCLC: HERTHENA-Lung01
|
Sep 10, 2023 |
|
JCO Article Insights: Introducing The Childhood Cancer Data Initiative
|
Aug 28, 2023 |
|
Impact of Heatwaves on the Care of Patients With Cancer
|
Aug 02, 2023 |
|
JCO Article Insights: Immunotherapy in People Living with HIV and Cancer
|
Jul 21, 2023 |
|
Racial/Ethnic Differences Discovered in Multigene Germline Testing of Early-Onset Colorectal Cancer
|
Jul 13, 2023 |
|
JCO Article Insights: Two New Prediction Models for Risk of Venous Thromboembolism in Cancer Patients
|
Jun 26, 2023 |
|
Olanzapine for Chemotherapy-Related Anorexia
|
Jun 22, 2023 |
|
PROSPECT Trial (Alliance N1048): PROs During and After Treatment for Locally Advanced Rectal Cancer
|
Jun 04, 2023 |
|
JCO Article Insights: Smoking Cessation for Patients with Cancer
|
May 29, 2023 |
|
JCO Article Insights: Use of Independently-Assessed vs Investigator-Assessed DFS in the APACT Trial
|
May 15, 2023 |
|
Peritumoral Anesthetic Infiltration Impacts Survival in Early Breast Cancer
|
May 11, 2023 |
|
Intensive Caring: Reminding Patients They Matter
|
Apr 27, 2023 |
|
Barriers to Clinical Trial Participation for Transgender People
|
Apr 13, 2023 |
|
JCO Article Insights: Trial Update on Development of Children After Maternal Cancer During Pregnancy
|
Mar 27, 2023 |
|
Cancer Screening During the 2nd Year of the COVID-19 Pandemic
|
Mar 23, 2023 |
|
Sequencing Matters – Combination Dabrafenib/Trametinib Versus Nivolumab/Ipilimumab for Advanced BRAF-Mutant Melanoma: The DREAMseq Trial
|
Mar 09, 2023 |
|
JCO Article Insights: Phase III POSEIDON Clinical Trial Results
|
Feb 27, 2023 |
|
One-Stop-Shop Comprehensive Cancer Screening Center Focused on Asymptomatic Screening
|
Feb 23, 2023 |
|
Improving Transparency in Phase 1 Clinical Trials
|
Feb 09, 2023 |
|
JCO Article Insights: Elderly Patients Receiving Chemotherapy for Early-Stage Breast Cancer
|
Jan 30, 2023 |
|
Ensuring Employment After Cancer Diagnosis
|
Jan 20, 2023 |
|
Intersectional Maxims for a New Era in Modern Medicine
|
Dec 09, 2022 |
|
Does Medicare Advantage Lead to a Disadvantage for Patients Who Need Surgery for Cancer?
|
Nov 21, 2022 |
|
Lack of Gender Equity in Oncology Clinical Trial Advisory Board Membership
|
Nov 03, 2022 |
|
Universal Germline Genetic Testing in GI Malignancies
|
Nov 01, 2022 |
|
Light From Darkness - Navigating Postmortem Tissue Donation
|
Sep 20, 2022 |
|
Physical Activity Improves Survival in Colorectal Cancer
|
Sep 12, 2022 |
|
Food Insecurity Interventions for Cancer Survivors With Dr. Francesca Gany and Dr. Theresa Hastert
|
Aug 29, 2022 |
|
How to Confront Climate Change: A Framework for Change in the Operating Room and Hospital as a Whole. A Conversation with Dr. Anaeze Offodile and Dr. Elizabeth Yates
|
Jun 17, 2022 |
|
JCO After Hours: A Discussion With Veena Shankaran and Scott Ramsey
|
Apr 01, 2022 |
|
JCO After Hours: A Discussion With Virginia Sun
|
Feb 21, 2022 |
|
JCO After Hours: A Discussion With Antonio Di Meglio
|
Feb 01, 2022 |
|
JCO After Hours: A Discussion With Abby Rosenberg and Reshma Jagsi
|
Jan 10, 2022 |
|
JCO After Hours: A Discussion With Michael Gnant and Kathy Miller
|
Dec 07, 2021 |
|
JCO After Hours: A Discussion With Kirsten Beyer and Jennifer Griggs
|
Nov 19, 2021 |
|
Is Dose-Adjusted EPOCH-R the Optimal Treatment for Children with Primary Mediastinal B-Cell Lymphoma?
|
Oct 20, 2021 |
|
Steroid Dose and Taxanes
|
Oct 10, 2021 |
|
Commentary on GROINSS VII
|
Sep 01, 2021 |
|
Harnessing the Power of Registries to Understand the Impact of Treatment for Hodgkin Lymphoma on Fertility
|
Aug 10, 2021 |
|
Subspecialty Palliative Care Involvement May Lessen the Need for High-Intensity End-of-Life Care for Adolescents and Young Adults With Cancer
|
Aug 01, 2021 |
|
Can the Incorporation of Minimal Residual Disease Detection Enhance Post-CAR T Outcomes in Patients With Large B-Cell Lymphoma?
|
Jul 10, 2021 |
|
Moving Forward With Venetoclax-Based Combinations in Younger Adults With Acute Myeloid Leukemia
|
Jun 20, 2021 |
|
A Deep Dive Into HLA Typing For Unrelated Donor Hematopoietic Cell Transplantation
|
May 20, 2021 |
|
PENELOPE-B: Exploration of CDK4/6 Inhibition in the Adjuvant Setting
|
May 10, 2021 |
|
ctDNA in DLBCL: A Blueprint for Better Clinical Trials?
|
Apr 10, 2021 |
|
How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?
|
Mar 10, 2021 |
|
The Pathologist, the Surgeon, and the Rare Phyllodes Tumor
|
Dec 20, 2020 |
|
Cancer Surgery in COVID-19-Free Facilities
|
Sep 29, 2020 |
|
Finding a Needle in a Haystack of Mutations: Using Whole Genome Sequencing to Identify Patients with Low-Risk Myeloma
|
Jul 20, 2020 |
|
Advancing Knowledge on the Use of Dexrazoxane in Children With Acute Myeloid Leukemia and Other Childhood Cancers
|
Jun 11, 2020 |
|
Better Diet – Fewer Side Effects?
|
Apr 30, 2020 |
|
Genetic Testing in Breast Cancer Patients: Striking the Balance Between Over Versus Undertesting
|
Mar 11, 2020 |
|
High Reward, High Toxicity: Combination Pembrolizumab and Lenvatinib in Advanced Endometrial Cancer
|
Mar 01, 2020 |
|
Optimizing Treatment Strategies for Germline BRCA/PALB2 Mutant Pancreatic Adenocarcinoma
|
Jan 21, 2020 |
|
Immune Checkpoint Inhibitor Use in Patients With Inflammatory Bowel Disease: A Closer Look
|
Jan 08, 2020 |
|
The High Prevalence of Exercise Intolerance in Adult Survivors of Childhood Cancer Is Predictive of All-Cause Mortality
|
Jan 08, 2020 |
|
Leptomeningeal Disease in EGFR-Mutated Lung Cancer: Can We Finally Define a Standard Treatment?
|
Jan 08, 2020 |
|
Advancing Treatment Options for Mismatch Repair-Deficient Metastatic Colorectal Cancers
|
Jan 08, 2020 |
|
Keeping Mycosis Fungoides in Check: A Study of Pembrolizumab for Relapsed/Refractory MF and Sezary Syndrome
|
Jan 06, 2020 |
|
What’s in a Name? An Introductory Guide
|
Dec 26, 2019 |
|
Resuming Life After Cancer Therapy: Treatment-Free Survival
|
Dec 10, 2019 |
|
Intratumoral Immune Infiltration in Follicular Lymphoma: Novel Insights into Early Relapse and Survival
|
Dec 01, 2019 |
|
MYC Rearrangements in Diffuse Large B-Cell Lymphoma: Impact and Implications for Diagnostic Testing
|
Nov 20, 2019 |
|
Centralization of High-Risk Surgery: Real Benefits for Patients From Health Systems
|
Nov 10, 2019 |
|
Microsatellite Instability as a Prognostic Marker for Resectable Gastric Cancer and a Potential Biomarker for Perioperative Chemotherapy Benefit
|
Nov 01, 2019 |
|
Radiotherapy Dose Reduction Is Possible With Induction Chemotherapy for Pediatric Nasopharynx Cancer
|
Oct 01, 2019 |
|
Fine Tuning Therapy for Intermediate-Risk Neuroblastoma Using Clinical Response and Tumor Biology
|
Sep 09, 2019 |
|
Déjà Vu or Predicted: The Failure of Dose Adjusted EPOCH-R to Improve Outcomes in Diffuse Aggressive Lymphomas
|
Jul 03, 2019 |
|
Tackling Stage III EGFR Mutation-Positive Lung Cancer: Do We Really Know How?
|
Jul 02, 2019 |
|
The Need for Continued Vigilance in Patients with Diffuse Large B-Cell Lymphoma
|
Jun 06, 2019 |
|
A Second Chance at Checkpoint Inhibition After Initial Immune-Mediated Diarrhea and Colitis
|
Jun 06, 2019 |
|
Anticipating the Future of Hodgkin Lymphoma
|
May 21, 2019 |
|
An Advance for the Treatment of Osteosarcoma
|
Apr 23, 2019 |
|
The Heartbreak of Cancer Treatment: The Latest in Late Cardiac Toxicity
|
Mar 13, 2019 |
|
Programmed Cell Death-1 Pathway Inhibitors Enter Center Stage as First-Line Treatment of Advanced Merkel Cell Carcinoma
|
Mar 08, 2019 |
|
Potential for Parenthood After Childhood Cancer: Perceptions and Reality
|
Feb 27, 2019 |
|
How Should We Interpret Indeterminate Pulmonary Nodules at Diagnosis in Children With Rhabdomyosarcoma?
|
Feb 08, 2019 |
|
The End of ENDoxifen Metabolite and CYP2D6 Testing in Tamoxifen-Treated Women?
|
Jan 24, 2019 |
|
Less is More: Precision Surveillance Imaging for Wilms Tumor
|
Oct 18, 2018 |
|
How Low Can You Go? Impact of Baseline Corticosteroid Use on Immunotherapy Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer
|
Aug 20, 2018 |
|
Expanding Treatment Options for Hormone Receptor-Positive, HER2-Positive Metastatic Breast Cancer
|
Aug 14, 2018 |
|
The Addition of Another Camptothecin Fails to Improve Outcomes in Patients With Intermediate-Risk Rhabdomyosarcoma
|
Aug 09, 2018 |
|
The Addition of IKZF1 Deletion in Risk Stratification for Children with Newly Diagnosed B-Acute Lymphoblastic Leukemia Leads to Improved Survival: Results of the Malaysia-Singapore ALL 2010 Study
|
Jul 26, 2018 |
|
Psychosocial Outcomes Following Contralateral Prophylactic Mastectomy: Insights and Opportunities
|
Jul 25, 2018 |
|
Risky Business: PD-1 Immune Checkpoint Blockade in Thymic Epithelial Neoplasms
|
Jun 18, 2018 |
|
Don't Treat Me Like a Child: The Intensification of Conventional Chemotherapy in Adults With Acute Lymphoblastic Leukemia
|
Jun 04, 2018 |
|
Multiple Myeloma Joins the Car T Race
|
May 29, 2018 |
|
Cardiotoxicity After Breast Cancer Radiotherapy: Which Part of the Heart Matters Most?
|
May 23, 2018 |
|
Should Prophylactic Cranial Irradiation Be Used in Patients with Stage III Non-Small Cell Lung Cancer?
|
May 22, 2018 |
|
The Medical Marijuana Conundrum: When Public Interest Outpaces Medical Knowledge
|
May 11, 2018 |
|
Racial Disparities in Medical Financial Hardship Among Cancer Survivors
|
Apr 18, 2018 |
|
Extending the Reach of Targeted Therapy for Hormone Receptor-Positive Advanced Breast Cancer
|
Apr 17, 2018 |
|
Late Infectious Death: Asplenic Adult Survivors of Child Cancer
|
Apr 17, 2018 |
|
An International Phase II Trial of Single-Agent Nivolumab for Hodgkin Lymphoma Relapsed or Refractory After Autologous Stem Cell Transplant
|
Mar 27, 2018 |
|
Exploring a New Delivery Model for Germline Genetic Testing for Patients With Ovarian Cancer
|
Mar 20, 2018 |
|
Is Earlier Treatment Better For Patients? The Case of Docetaxel in Metastatic Castration-Sensitive Prostate Cancer
|
Mar 09, 2018 |
|
The Decision to Image Breast Cancer Patients with Local-Regional Recurrence
|
Jan 31, 2018 |
|
The Importance of Reading Clinical Trial Protocols Simultaneously With Published Studies
|
Jan 24, 2018 |
|
Understanding the 'Value-Added' by Specialized Pediatric Palliative Care Teams in the Care of Children With Cancer at the End of Life
|
Jan 22, 2018 |
|
Survival Following Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Early-Stage Hepatocellular Carcinoma
|
Jan 12, 2018 |
|
The True Costs of the 21-Gene Assay in a Cohort of 1,000 Patients
|
Dec 01, 2017 |
|
Persistent Use of Opioids After Cancer Surgery
|
Oct 19, 2017 |
|
Discussion on the Cost–Effectiveness Analysis of the CALGB/Alliance Trial and the Use of Zoledronic Acid Generic in Women With Metastatic Breast Cancer
|
Oct 12, 2017 |
|
Can We Simplify the Treatment of Myelofibrosis?
|
Sep 21, 2017 |
|
Lessons to be Learned about the Significance of Educational Level in Adults with Acute Myeloid Leukemia
|
Sep 11, 2017 |
|
More Often but Not Early: Hospice Use Among Older Adults With AML
|
Aug 17, 2017 |
|
T-cell Therapy for Viral Infections after Stem Cell Transplant
|
Aug 17, 2017 |
|
Shared Risk Factors in Cancer and Cardiovascular Disease: Can We Make a Difference?
|
Jul 12, 2017 |
|
Should Metabolic Imaging to Assess Minimal Residual Disease (MRD) Become a Clinical Endpoint in Multiple Myeloma?
|
Jul 07, 2017 |
|
Considerations in Predicting Neuropsychological Outcomes in Children Treated for ALL
|
Jul 03, 2017 |
|
Low-Income Subsidy and Financial Barrier to Access Costly Oral Chemotherapy Drugs for Myeloma Patients Enrolled in Medicare Part D
|
Jun 08, 2017 |
|
Beyond the Beam: Thinking about Subsequent Malignancy Risk Outside of the Radiation Paradigm,”
|
May 22, 2017 |
|
Discussion of the SWORD-Study and Fear of Cancer Recurrence Intervention Research Randomized Controlled Trial
|
May 12, 2017 |
|
Optimizing Up-Front Therapy for Double-Hit Lymphoma
|
May 05, 2017 |
|
Chronic Conditions in Cancer Survivors
|
May 04, 2017 |
|
Do Treatment Summary Survivorship Plans Make Any Difference?
|
Apr 18, 2017 |
|
The Impact of Cigarette Smoking on Survival in Patients with Pancreatic Cancer
|
Mar 30, 2017 |
|
Better Patient-Reported Outcomes After Autologous Breast Reconstruction Compared to Implant-Based Reconstruction Study
|
Mar 28, 2017 |
|
Drugs Don't Work in Patients Who Don't Take Them
|
Mar 24, 2017 |
|
Pembrolizumab is Safe and Active in Platinum- and Cetuximab-Refractory Head and Neck Squamous Cell Carcinoma
|
Mar 22, 2017 |
|
Long-Term Follow-up of AF-001JP: A Phase I/II Study of Alectinib in ALK-Positive NSCLC
|
Mar 15, 2017 |
|
Late Relapse in Hodgkin Lymphoma Persisting Even at 20 Years: Implications for Therapeutic Intensity and Disease Biology
|
Feb 28, 2017 |
|
Intensification of Consolidation Therapy for Acute Myeloid Leukemia by the Addition of Clofarabine to Cytarabine Improves Relapse-Free Survival
|
Feb 21, 2017 |
|
Characterizing the Patterns of Clonal Evolution in Ibrutinib-Treated CLL: A Roadmap for Continued Progress
|
Feb 13, 2017 |
|
Prevalence of Germline Mutations in Individuals With Colorectal Cancer as Determined Using a Multi-Gene Panel Test
|
Jan 30, 2017 |
|
Financial Barriers to Cancer Care for Patients Obtaining Insurance on the Federal Exchange
|
Jan 11, 2017 |
|
Mindfulness-Based Interventions in Oncology: Not for Everyone?
|
Nov 21, 2016 |
|
The Impact of Oral Targeted Therapies on the Cost of Care for Patients With Chronic Lymphocytic Leukemia
|
Nov 21, 2016 |
|
Watching Nivolumab’s Balancing Act: How Immune Activation May Affect Both Safety and Efficacy in Patients With Advanced Melanoma
|
Nov 14, 2016 |
|
Getting to the Heart of the Matter: Biomarkers for the Assessment of Trastuzumab-Induced Cardiac Dysfunction
|
Oct 26, 2016 |
|
Listen to Your Patients
|
Oct 03, 2016 |
|
Impact of Organizational Characteristics and Process of Care on Hospital Mortality and Resource Use in Cancer Patients Admitted to Intensive Care Units
|
Sep 13, 2016 |
|
Health-Related Quality of Life: Increasingly Important in the Era of Effective, Modern Myeloma Therapy
|
Sep 06, 2016 |
|
Chemotherapy Induced Peripheral Neuropathy: A Novel Method of Exploration
|
Aug 14, 2016 |
|
Changes in the Epidemiology of AIDS-Related Kaposi’s Sarcoma and Lymphomas: How This Informs the Clinician
|
Aug 08, 2016 |
|
Implicit Racial Bias Affects Key Aspects of Physician Communication
|
Jul 14, 2016 |
|
Nivolumab Monotherapy is Safe and Active in Hematologic Malignancies
|
Jul 14, 2016 |
|
Minimizing Frailty in Cancer Survivors: A Meaningful Goal for All Ages
|
Jul 13, 2016 |
|
1q Gain, a Prognostic Biomarker in Nephroblastoma, and What’s Next?
|
Jul 11, 2016 |
|
Therapy Impacts Long-Term Survival for Patients in Germany With Heritable Retinoblastoma
|
Jul 05, 2016 |
|
Dexamethasone and High-Dose Methotrexate in High-Risk B Cell Acute Lymphoblastic Leukemia—Where Should We Go From Here?
|
Jul 01, 2016 |
|
Unraveling the Significance of Mismatch Repair Deficiency in Women With Endometrioid-type Endometrial Adenocarcinoma
|
Jun 20, 2016 |
|
Nodal Status After Neoadjuvant Chemotherapy Determines Prognosis in Localized Gastric Cancer
|
Jun 13, 2016 |
|
Restrictions on Nutrition, Social Contacts, and Pets Are Not Effective Anti-Infective Measures in Children With Acute Myeloid Leukemia
|
Jun 06, 2016 |
|
Current Status of Supplemental Screening in Dense Breasts
|
May 23, 2016 |
|
Selective Internal Radiation Therapy for Liver-Dominant Metastatic Colorectal Cancer: Time to Put the Brakes On?
|
May 11, 2016 |
|
Prognostication Based on Site of Metastatic Disease in Castration Refractory Prostate Cancer: Implications for Patient Care and Clinical Trial Design
|
May 03, 2016 |
|
IgM-Related AL Amyloidosis: A Rare Form of a Rare Disease
|
Apr 25, 2016 |
|
Quality of Life: A Critical Consideration in Women Diagnosed with Ductal Carcinoma in Situ
|
Apr 12, 2016 |
|
Very Late Outcomes of Wilms Tumor Survivors: British Childhood Cancer Study
|
Mar 29, 2016 |
|
Web-Based Technology Can Improve Patient Understanding and Preparedness to Discuss Cancer Clinical Trials: One Step Towards a Goal of Increased Enrollment
|
Mar 11, 2016 |
|
How Should We Manage the Financial Toxicity of Cancer Treatment?
|
Mar 09, 2016 |
|
Prognostication in Mantle Cell Lymphoma
|
Feb 29, 2016 |
|
Sunbelt Melanoma Trial: A Seminal Adjuvant Interferon Trial with Long Term Results
|
Feb 08, 2016 |
|
Race for the Cure: How differences in Race and Ethnicity Impact the Diagnosis and Survival of T-Cell Lymphoma
|
Jan 25, 2016 |
|
Clinical Drug Development for Non-Muscle-Invasive Bladder Cancer…Definitions Matter
|
Jan 25, 2016 |
|
Hepatocellular Carcinoma in Children and Adolescents: Time for a Strategy and a Trial
|
Jan 25, 2016 |
|
Epidural Spinal Cord Compression: The Importance of Multi-disciplinary Treatment Planning
|
Jan 12, 2016 |
|
Expanding Immunotheapy Benefit in Metastatic RCC
|
Jan 11, 2016 |
|
Hard to RECIST: Updating and Simplifying Primary Tumor Response Guidelines for the Revised International Neuroblastoma Response Criteria (INRC)
|
Jan 11, 2016 |
|
A New Oncogene Target in Lung Cancer: Exon 14 Alterations in the MET Gene
|
Jan 04, 2016 |
|
The Evolution of the Polycythemia Vera Symptom Burden: Implications for a Changing Treatment Paradigm
|
Dec 30, 2015 |
|
The Emerging Role of Gallium-68 Somatostatin-Receptor PET Imaging in Neuroendocrine Tumors
|
Dec 28, 2015 |
|
Dexrazoxane for childhood cancer patients – ready for prime time?
|
Dec 23, 2015 |
|
Uterine lavage: a new approach to gynecologic cancer detection?
|
Nov 09, 2015 |
|
Defining the Optimal Interval for Colonoscopic Screening in Individuals with a Family History of Colorectal Cancer
|
Nov 02, 2015 |
|
Hormonal Therapy is Out for Meningiomas: Time to Change Tactics?
|
Nov 02, 2015 |
|
Using the CLIC Study of Outcome in Advanced Stages of Mycosis Fungoides and Sezary Syndrome to Guide Treatment And Clinical Research
|
Oct 05, 2015 |
|
Geographic Access as a Barrier to Adjuvant Chemotherapy for Patients with Stage III Colon Cancer
|
Aug 24, 2015 |
|
Host Factors and Lynch Syndrome Patients: Weighing Role of Obesity and Aspirin and Risk of Colorectal Cancer
|
Aug 17, 2015 |
|
To Stop or Not to Stop: That is the Question
|
Aug 17, 2015 |
|
The Promise and the Pitfalls of Population-Wide Screening of BRCA1 and BRCA2
|
Aug 17, 2015 |
|
Breast Cancer and Weight Loss: Where Do We Go from Here?
|
Aug 17, 2015 |
|
Intraperitoneal Therapy for Ovarian Cancer: No More Excuses
|
Aug 06, 2015 |
|
Balancing Safety and Efficacy in the Treatment Hodgkin Lymphoma: Early Discontinuation of Certain Drugs Can and Should Be Done
|
Jun 22, 2015 |
|
When Toxicity and Efficacy Collide
|
Jun 08, 2015 |
|
First Results of Euramos I and Logistics of International Collaboration for Clinical Trials of Rare Diseases
|
Jun 01, 2015 |
|
Treatment Advances in Local-Regionally Advanced and Stage IVB/Recurrent Cervical Cancer: Can We Agree that More Isn’t Always Better?
|
May 18, 2015 |
|
Building Blocks in the Case for Adjuvant Therapy in Biliary Tract Cancers
|
May 11, 2015 |
|
Androgen Deprivation Therapy for Prostate Cancer - Friend or Foe to the Psyche?
|
May 11, 2015 |
|
Aromatase Inhibitor Arthralgias: Identification, Treatment Options and Research Perspectives
|
May 04, 2015 |
|
Deciphering the Heterogeneity Within EGFR-mutant Lung Cancer
|
Apr 20, 2015 |
|
Precision Immunology: The Promise of Tumor Immunotherapy for the Treatment of Cancer
|
Apr 15, 2015 |
|
The Importance of Discussing Genetics with Every Breast Cancer Patient
|
Apr 14, 2015 |
|
Hematopoietic Stem Cell Transplant for Children With Acute Lymphoblastic Leukemia at BFM Centers: Comparable Results With Matched Sibling Donors and Matched Unrelated Donors
|
Mar 19, 2015 |
|
Is It Biology or Brawn in Ovarian Cancer Surgery?
|
Feb 09, 2015 |
|
Mirror Views: Reflections of Complementary Perspectives in Patient and Clinician Toxicity Reporting
|
Feb 05, 2015 |
|
Dynamic Evolution of ALK Positive Non-Small Cell Lung Cancers and Management of Associated Brain Metastases
|
Jan 23, 2015 |
|
Prediction of Breast Cancer Risk After a Benign Breast Biopsy: A Practical Model?
|
Jan 21, 2015 |
|
Prophylactic Anticoagulation in High-Risk Metastatic Germ Cell Tumor Patients: Who Should We Treat?
|
Jan 21, 2015 |
|
The Risk of Second Cancers for Patients with Endometrial and Rectal Cancer Receiving Radiation Therapy
|
Dec 22, 2014 |
|
Better Outcome of Chemo-Irradiation of Head and Neck Cancer in High-Patient-Volume Institutions
|
Dec 08, 2014 |
|
The Treatment of Insomnia in Cancer Patients
|
Dec 01, 2014 |
|
Is There a Future for Cyclooxygenase-2 Inhibition in Non-Small Cell Lung Cancer?
|
Dec 01, 2014 |
|
The Biopsy Study: How the Use of Multiple Colposcopic-Directed Biopsies Improves Detection of Cervical Precancers
|
Nov 25, 2014 |
|
Intensified Frontline Chemoimmunotherapy with R-ACVBP May Improve Outcomes for Younger Patients with Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
|
Nov 25, 2014 |
|
A Positive Study of DTC-Guided Secondary Adjuvant Treatment in Early Breast Cancer: Ready for Prime Time?
|
Nov 25, 2014 |
|
A Second Course of Radiation Therapy for Painful Osseous Metastases Improves Patient Function and Quality of Life
|
Nov 25, 2014 |
|
Adjuvant Trastuzumab Passes the Test of Time
|
Nov 25, 2014 |
|
Prognostic Value of BRAF V600 E Mutation in Papillary Thyroid Cancer
|
Nov 25, 2014 |
|
Biochemotherapy: As Time Goes By?
|
Nov 25, 2014 |
|
The First Prospective Trial of Proton Therapy for Children With Rhabdomyosarcoma: What We Learn From Preliminary Results
|
Nov 25, 2014 |
|
Intermediate Risk Pediatric Hodgkin Lymphoma: Early Response-Adapted Treatment Is Key
|
Nov 25, 2014 |
|
Keeping Older Cancer Patients out of the Hospital: A Community Affair
|
Nov 25, 2014 |
|
Optimal Duration of MRD Monitoring During Therapy for Childhood ALL
|
Nov 25, 2014 |
|
Hepatitis B Reactivation in Patients Receiving Rituximab Can Be Detected Early and Managed with Antivirals
|
Nov 25, 2014 |
|
CT or No CT: An Important Question in Diffuse Large B-Cell Lymphoma
|
Sep 29, 2014 |
|
Glembatumumab Vedotin (CDX-011, CR011-vcMMAE): On The Brink Of Targeted Therapy For Triple-Negative Breast Cancer?
|
Sep 29, 2014 |
|
Post-Transplant Cyclophosphamide for GVHD Prophylaxis: Back to the Future
|
Sep 29, 2014 |
|
The Price Of A Drug is Not the Whole Cost
|
Sep 29, 2014 |
|
Cabozantinib in Advanced Prostate Cancer: Is the Therapeutic Window Too Narrow?
|
Sep 15, 2014 |
|
Fracture Risk after Cystectomy: Don't Ignore It
|
Sep 02, 2014 |
|
Is Hematopoietic Stem Cell Transplantation of Value in Treating Systemic Mastocytosis?
|
Aug 26, 2014 |
|
Significant Dose Effect of Radiotherapy to the Pancreas and Risk of Diabetes Mellitus in Long-Term Hodgkin Lymphoma Survivors
|
Aug 26, 2014 |
|
The End of Rituximab Maintenance for Low Tumor Burden Follicular Lymphoma
|
Aug 26, 2014 |
|
Use of Mutational Analysis to Help Decide Whether Patients with Myelodsysplastic Syndromes Should Receive Allogeneic Hematopoietic Cell Transplant
|
Aug 26, 2014 |
|
Why are Fellows' Burnout Rates as High as Those of Practicing Oncologists?
|
Jul 21, 2014 |
|
Surprisingly Good Results in BCR-ABL1-like Pediatric Acute Lymphoblastic Leukemia: What Do They Mean?
|
Jul 21, 2014 |
|
Should Corticosteroids Be Used for the Treatment of Pain, Fatigue and Loss of Appetite in Cancer Patients Receiving Opioids?
|
Jul 07, 2014 |
|
Breast Reconstructions: Inequities in Access Affecting Choice and Quality
|
Jul 03, 2014 |
|
Recurrent/Metastatic Human Papillomavirus-Associated Oropharynx Cancer: What Happens When This Good Prognostic Cancer Misbehaves?
|
Jun 23, 2014 |
|
Long Term Cardiac Safety Data from the HERA Adjuvant Trastuzumab Trial
|
Jun 09, 2014 |
|
Breast Needle Core Biopsy: The Impact Surgeons and Geography Have on Utilization and the Impact on Patient Care
|
Jun 09, 2014 |
|
Identifying High-Risk Myeloma
|
Jun 02, 2014 |
|
Attempting to Avoid Chemotherapy in CLL with Lenalidomide and Rituximab
|
May 27, 2014 |
|
Breast Cancer Chemotherapy Effects on Brain Activation During Multitasking and Relation to Cognitive Complaints
|
May 27, 2014 |
|
Delayed Diagnostic Lumbar Puncture to Optimize Central-Nervous-System-Directed Therapy in Childhood Acute Lymphoblastic Leukemia
|
May 12, 2014 |
|
Capecitabine Versus Continuous Infusion 5-FU for Rectal Cancer Neoadjuvant Chemoradiation: Equivalent Effectiveness Raises Real-World Questions About Efficacy, Adherence and Economic Implications
|
May 05, 2014 |
|
Evolving Treatment Paradigms for Primary Mediastinal Diffuse Large B-Cell Lymphoma
|
May 05, 2014 |
|
Response Assessment in Hodgkin Lymphoma: Size Matters!
|
May 05, 2014 |
|
Second Tumors in PTEN Mutation-Positive Patients: Are They Recurrences or New Primaries?
|
Apr 28, 2014 |
|
Are Partners of Patients HPV-Positive Oropharyngeal Cancer at Increased Risk of Infection and Cancer?
|
Apr 28, 2014 |
|
Planning to Survive: The Role of Physicians
|
Apr 21, 2014 |
|
Minimal Residual Disease (MRD) Study to Optimize Definition and Therapy of High-Risk Acute Lymphoblastic Leukemia
|
Apr 21, 2014 |
|
Risk-Reducing Oophorectomy in Women with BRCA1 and BRCA2 Mutations: An Opportunity to Personalize Recommendations for Cancer Prevention
|
Mar 31, 2014 |
|
Anti-EGFR Monoclonal Antibodies in the First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The PEAK Experience
|
Mar 31, 2014 |
|
Accuracy of BRCAPRO in Women with Ovarian Cancer
|
Mar 17, 2014 |
|
Serious Bevacizumab-Associated Gastrointestinal Toxicity
|
Mar 17, 2014 |
|
The Efficacy of Bevacizumab Combined with Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer Patients and Its Effects On Patient-Reported Outcomes
|
Mar 17, 2014 |
|
Nivolumab: Promising Survival Signal Coupled with Limited Toxicity Raises Expectations
|
Mar 03, 2014 |
|
Decision Shared or Otherwise-: The Ongoing Evolution of Local Therapy for Breast Cancer
|
Feb 18, 2014 |
|
Is Early Initiation of Adjuvant Chemotherapy for Breast Cancer Better?
|
Feb 10, 2014 |
|
Single Agent Rituximab Active in Nodular Lymphocyte Predominant Hodgkin Lymphoma
|
Feb 10, 2014 |
|
Adjuvant Treatment for Gastric Cancer: The Story Continues to Evolve
|
Feb 10, 2014 |
|
Benefits of Modified Craniospinal Radiation Therapy for Children Treated for Medulloblastoma: Preserving Long-Term Neurocognitive Function
|
Feb 10, 2014 |
|
Breast MRI As It Is, In Contrast To How We Wish It To Be
|
Jan 06, 2014 |
|
New Adoptive T Cell Therapy Has EBV-Positive Lymphomas on the Run
|
Dec 16, 2013 |
|
Adjuvant High-Dose Interferon: New Evidence Regarding Treatment Duration and Survival Impact in Melanoma
|
Dec 16, 2013 |
|
Some like It Even Hotter: Escalating Radioimmunotherapy in Follicular Lymphoma?
|
Dec 02, 2013 |
|
Increasing Cytarabine Dose in AML Induction Improves Outcomes in Younger Patients
|
Dec 02, 2013 |
|
The Value of Preoperative MRI in Predicting Outcome in Patients with Rectal Cancer
|
Nov 25, 2013 |
|
Refining Stringency of Response in Myeloma
|
Nov 18, 2013 |
|
When Hodgkin Lymphoma Relapses in The Older Patients
|
Nov 04, 2013 |
|
How Do We Decide Who Should Be Offered a Sentinel Node Biopsy When Their Melanoma Is Less than 1mm in Thickness?
|
Nov 04, 2013 |
|
FISH for Smoldering Multiple Myeloma
|
Nov 04, 2013 |
|
External Beam Accelerated Partial Breast Irradiation: Exploring the Limits of Tolerability
|
Oct 09, 2013 |
|
Minimal Residual Disease (MRD) in Acute Myeloid Leukemia- Are we Ready for Individualized Risk Assessment Based on MRD?
|
Sep 23, 2013 |
|
Functional Imaging as a Biomarker for Survival in Locoregionally Advanced Non-Small Cell Lung Cancer Patients
|
Sep 16, 2013 |
|
EORTC 18961 GMK Vaccine Adjuvant Trial: Unfulfilled Promise for Another Vaccine Trial
|
Sep 09, 2013 |
|
Lenalidomide Monotherapy for Relapsed Mantle Cell Lymphoma
|
Sep 03, 2013 |
|
Flying Solo: Chemotherapy Without Radiation for Primary Central Nervous System Lymphoma
|
Aug 26, 2013 |
|
Second Hematopoietic Transplants for Relapsed AML
|
Aug 05, 2013 |
|
In End-Of-Life Decision-Making, Does DNR Measure Up?
|
Jul 29, 2013 |
|
A Clear Answer to the Wrong Question
|
Jul 12, 2013 |
|
Bisphosphonate-Related Osteonecrosis of Jaw (BOJN) in the Adjuvant Breast Cancer Setting: Risks and Perspective
|
Jun 24, 2013 |
|
Should Myeloma Residual Disease Become a Standard Assay for Large Cooperative Groups and Myeloma Referral Centers?
|
Jun 03, 2013 |
|
The Prognosis of Breast Cancer Diagnosed During Pregnancy
|
Jun 03, 2013 |
|
The SUCCEED Trial: Maintenance Ridaforolimus for Metastatic Soft- Tissue Sarcomas
|
May 30, 2013 |
|
Who Needs What Therapy? The Elusive Search for Predictive Markers
|
May 06, 2013 |
|
Micro RNAs and Other Molecular Markers in AML Therapeutics
|
May 06, 2013 |
|
Neuroanatomic and Neuropsychological Outcomes in Adults after Treatment for Childhood Acute Lymphoblastic Leukemia
|
Apr 15, 2013 |
|
HERA Indicates that Adjuvant Trastuzumab Confers Equal Benefit for HER2-Positive Invasive Ductal and Invasive Lobular Breast Cancers
|
Apr 15, 2013 |
|
New Evidence of the Clinical Significance of Cigarette Smoking by Colon Cancer Patients
|
Apr 01, 2013 |
|
Radiotherapy for Pediatric Hodgkin Lymphoma: Are We Ready To Say Goodbye?
|
Mar 18, 2013 |
|
Minimal-Intensity Conditioning: A Decade Later
|
Mar 11, 2013 |
|
Evolution of Concurrent Chemoradiation Treatment Approaches in Head and Neck Cancer
|
Mar 05, 2013 |
|
Off-Label Cancer Therapy Use: How Much is Too Much?
|
Feb 19, 2013 |
|
Caring For Patients With Transformed Follicular Lymphoma
|
Feb 12, 2013 |
|
Outpatient Therapy for Fever and Neutropenia is Safe But Implementation is the Key
|
Jan 28, 2013 |
|
Outcomes in Cancer Survivors Who Develop Second Malignant Neoplasms
|
Jan 22, 2013 |
|
Molecular Profiling of Gastric Cancer: Toward Personalized Cancer Medicine
|
Jan 22, 2013 |
|
Reflections on "Cancer Survivorship": Evolution, Utility, and Acceptability
|
Jan 03, 2013 |
|
Estimating the Risk for Contralateral Breast Cancer as a Guide for Surgical Treatment
|
Jan 03, 2013 |
|
Revisiting Combination TACE-RFA Treatment for HCC
|
Jan 03, 2013 |
|
Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma
|
Dec 19, 2012 |
|
Successful Non-Intensive Bridging of MDS Patients Towards Allografting
|
Dec 19, 2012 |
|
Using a Video Decision Support Tool for CPR Decision-Making
|
Dec 11, 2012 |
|
Radioimmunotherapy for the Initial Treatment of Follicular Lymphoma
|
Dec 11, 2012 |
|
Management of Metastases to the Brain: A Therapeutic Conundrum
|
Dec 03, 2012 |
|
Understanding the Role of MET Kinase in Cancer Therapy
|
Dec 03, 2012 |
|
AIDS Related Lymphomas - More Options and More Questions
|
Nov 19, 2012 |
|
Long Term Follow-up of NSABP B-31: How Well Can We Predict Cardiac Toxicity with Trastuzumab?
|
Nov 16, 2012 |
|
More Adjuvant Chemotherapy is Not Always Better
|
Nov 16, 2012 |
|
Hodgkin Lymphoma: Protecting the Victims of Our Success
|
Nov 13, 2012 |
|
Beyond the Plasma Cell: Proteasome Inhibition in Acute Myelogenous Leukemia
|
Nov 02, 2012 |
|
Breast Brachytherapy in the United States: Increasing Use Despite Increased Complication Rates
|
Nov 01, 2012 |
|
Referral Practices to Palliative Care Among Canadian Oncologists
|
Nov 01, 2012 |
|
Clinical Utility of Screening Tests in Asymptomatic Long-Term Childhood Cancer Survivors
|
Nov 01, 2012 |
|
Is Lymphatic Mapping Ready for Clinical Use in the Treatment of Squamous Vulvar Cancer?
|
Oct 30, 2012 |
|
Rituximab Maintenance Therapy After Autologous Stem Cell Transplantation: Final Analysis of the CORAL Trial
|
Oct 23, 2012 |
|
Informed Consent for Pediatric Phase I Cancer Trials: An End-of-Life Decision
|
Oct 15, 2012 |
|
Outcome in Systemic Anaplastic Large Cell Lymphoma: Beyond ALK
|
Oct 08, 2012 |
|
Should Gemtuzumab Ozogamicin Be Re-added to the Therapeutic Armamentarium for Acute Myeloid Leukemia?
|
Sep 17, 2012 |
|
Immunohistochemical Double Hit Score in Diffuse Large B-Cell Lymphoma: The Potential to Screen All Tumors for High-Risk Biology
|
Sep 04, 2012 |
|
In a Sea of Data the Water is Still Murky: Meta-Analysis of Cognition in Breast Cancer
|
Aug 27, 2012 |
|
KRAS G13D Mutations in Metastatic Colorectal Cancer: Are They Different From Codon 12?
|
Aug 24, 2012 |
|
Taxane Induced Peripheral Neuropathy: A Continued Challenge but Not a Biomarker of Treatment Efficacy
|
Aug 10, 2012 |
|
Is This Nomogram Ready To Roll?
|
Jun 25, 2012 |
|
Adjuvant Chemotherapy in Older Patients with Stage III Colon Cancer
|
Jun 04, 2012 |
|
The Combination of Bortezomib, Thalidomide, and Dexamethasone in Relapsed Multiple Myeloma
|
May 14, 2012 |
|
Personalized Therapy for Breast Cancer: Is It Really Happening?
|
May 09, 2012 |
|
Routine Second Pathology Review for Node-Negative Breast Cancer: What is Learned and What is the Effect on Patient Care?
|
May 07, 2012 |
|
Pre-Operative Metformin in Early-Stage Breast Cancer
|
May 07, 2012 |
|
Fulvestrant and Anastrozole in Combination: FACT or Fiction?
|
Apr 30, 2012 |
|
A New Day Dawning for Hodgkin Lymphoma?
|
Apr 30, 2012 |
|
The German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow Up of 11 Years: Implications of Long Term Follow Up
|
Apr 23, 2012 |
|
Carboplatin-Gemcitabine-Bevacizumab: Expanding Treatment Options for Recurrent Platinum Sensitive Epithelial Ovarian Cancer
|
Apr 23, 2012 |
|
The Use of Adjuvant Therapy in Elderly Patients with Resected Non-Small Cell Lung Cancer (NSCLC)
|
Apr 23, 2012 |
|
Management and Prevention of Pain Related to Treatment or Disease
|
Apr 16, 2012 |
|
1 + 1 = 3. Combined Use of Anti-HER2 Agents in the Neoadjuvant Setting
|
Apr 09, 2012 |
|
Management of Low Stage Ovarian Clear Cell Carcinoma
|
Apr 09, 2012 |
|
Surviving Childhood Cancer: Defining Risk of Poor Cardiac Outcomes in Early and Middle Adulthood
|
Apr 02, 2012 |
|
No Advantage to Combining Cetuximab with 5FU, Leucovorin, and Oxaliplatin in Metastatic Colorectal Cancer
|
Apr 02, 2012 |
|
Sorting Through Early Melanomas to Identify Those at Higher Risk for Metastases
|
Mar 12, 2012 |
|
Sedation for the Management of Refractory Suffering
|
Mar 12, 2012 |
|
The Role of the Estrogen Receptor (ER) in Selecting Women, Diagnosed with DCIS for Adjuvant Therapy with Tamoxifen
|
Mar 05, 2012 |
|
How Cooperative Group Trials Impact Breast Cancer Care in United States
|
Mar 05, 2012 |
|
What's Different Between One Colorectal Cancer and Another? It's All in the Genes
|
Mar 05, 2012 |
|
Molecular Tumor Analyses Followed by First Line Oral Tyrosine Kinase Inhibitors in Lung Adenocarcinomas with Driver Abnormalities
|
Feb 28, 2012 |
|
Placing the P Value into Perspective: Does Paclitaxel Add Value to Gemcitabine and Cisplatin in Advanced Urothelial Cancers?
|
Feb 28, 2012 |
|
Early Stage Hodgkin Lymphoma -- How Much is Enough?
|
Feb 21, 2012 |
|
The Rich Get Richer: Another Efficacious Option for Refractory Hairy Cell Leukemia
|
Feb 21, 2012 |
|
Rethinking Our Use of CSFs in the Adjuvant Treatment of Women Who Have Estrogen Receptor Positive Cancers
|
Feb 06, 2012 |
|
Recurrence and Survival Results of the GOG Lap2 Trial Confirm Safety of the Laparoscopic Approach to Surgical Staging and Treatment for Uterine Cancer
|
Jan 30, 2012 |
|
"Anything You Can’t Do, I Can’t Do Either": Transplantation for High Risk AML
|
Jan 30, 2012 |
|
Safety and Efficacy of Sequential Adjuvant AI Therapy in ER Positive Breast Cancer
|
Jan 19, 2012 |
|
The Role of Ovarian Suppression for Fertility Preservation in Women Receiving Adjuvant Breast Cancer Chemotherapy
|
Jan 09, 2012 |
|
Using BCR-ABL Transcript Levels After 3 Months of Therapy on Imatinib is the Best Way to Predict Long-Term Outcome for Patients with CML Treated with Imatinib
|
Jan 09, 2012 |
|
The Importance of Tumor Biopsies for Analysis of Mechanisms of Response and Resistance in Prostate Cancer
|
Dec 19, 2011 |
|
Targeting the Angiopoietin-Tie2 Axis: A Promising Alternative Antiangiogenic Strategy for Epithelial Ovarian Cancer
|
Dec 19, 2011 |
|
Interim PET Scans in Diffuse Large B-Cell Lymphoma - More Than Another Biomarker?
|
Dec 12, 2011 |
|
To Biopsy or Not to Biopsy? That is the Question
|
Dec 07, 2011 |
|
Disparities in Systemic Therapy for Breast Cancer
|
Dec 05, 2011 |
|
Adjusting for Treatment Cross-Over to Enable Analysis of Longer Term Outcomes in the MA.17 Trial
|
Nov 28, 2011 |
|
Obesity and Colorectal Cancer: What's the Big Deal?
|
Nov 28, 2011 |
|
Combinations or Single Agents, Crossover or No Crossover: Considering Chemotherapy Strategies in the Multi-Chaptered Story of Metastatic Breast Cancer
|
Nov 14, 2011 |
|
Medical Oncologist Attitudes and Practice in Cancer Pain Management: A National Survey
|
Nov 14, 2011 |
|
Is a "Wait and See" Nonoperative Approach Justified after Chemoradiation for Rectal Cancer
|
Nov 07, 2011 |
|
Predictive Testing for BRCA1/2 Mutations: The Value of the "True"Negative
|
Oct 31, 2011 |
|
Trastuzumab in the Adjuvant Setting - Sequential versus Concurrent: Will We Ever Know the Full Answer?
|
Oct 31, 2011 |
|
Solving the Mystery of Recurrence in "Surgical Cures" for Early Non-Small Cell Lung Cancer
|
Oct 11, 2011 |
|
Comorbidity Data in Cooperative Trials: Feasible and Non Ignorable
|
Oct 11, 2011 |
|
Gender Equity and HPV-Associated Cancers in the United States
|
Sep 29, 2011 |
|
Biomarker Selection for Maintenance Therapy in Advanced NSCLC
|
Sep 29, 2011 |
|
Osteonecrosis in Pediatric Acute Lymphoblastic Leukemia
|
Sep 26, 2011 |
|
R-CHOP Chemotherapy as Upfront Treatment for Advanced Stage Follicular Non-Hodgkin Lymphoma
|
Sep 15, 2011 |
|
Venlafaxine and Clonidine for Treatment of Hot Flashes in Women with Breast Cancer
|
Sep 12, 2011 |
|
Response to Neoadjuvant Systemic Therapy for Breast Cancer in BRCA Mutation Carriers and Non-Carriers: A Single Institution Experience
|
Aug 31, 2011 |
|
Individualizing the Risk of Cardiovascular Mortality Following Androgen Deprivation Therapy for Prostate Cancer
|
Aug 15, 2011 |
|
High Risk Stage II Colon Cancer: What is the Role of Adjuvant Chemotherapy?
|
Jul 21, 2011 |
|
Is Genotype Guided Tamoxifen Dosing Ready for Prime Time?
|
Jul 18, 2011 |
|
Menopausal Hormone Therapy, Mammographic Density and Breast Cancer
|
Jun 23, 2011 |
|
The Growing Value of Risk Calculators for Men Considering Prostate Cancer Screening
|
Jun 20, 2011 |
|
Interpretation of the Biomarker Analysis and Final Overall Survival Results from IPASS
|
Jun 13, 2011 |
|
Curing Leukemia with a Single Drug
|
Jun 06, 2011 |
|
Vaccination with an Autologous Idiotype Based Vaccine Following a Chemotherapy Induced Remission Holds Promise in the Treatment of Patients with Follicular Lymphoma
|
May 31, 2011 |
|
Pathologic Complete Response and Toxicity Results from the STAR-01 Trial Evaluating the Addition of Oxaliplatin to Neodjuvant Chemoradiation for Locally Advanced Rectal Cancer
|
May 23, 2011 |
|
MEK Inhibitors
|
May 16, 2011 |
|
Angiogenic Therapy in Breast Cancer: Axitinib with Chemotherapy Joins the Crowd
|
May 09, 2011 |
|
Advanced Radiation Therapy Technology Improves Survival in Lung Cancer
|
May 02, 2011 |
|
The Dark Side of del(5q) MDS
|
Apr 25, 2011 |
|
Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer: Is it Ready for Prime Time?
|
Apr 18, 2011 |
|
Are Lung Cancers with BRAF Mutations Another Molecularly Defined Subgroup of Patients?
|
Apr 11, 2011 |
|
Targeting the VEGF Receptor in Colon Cancer: Lessons Learned from Negative Trials
|
Apr 04, 2011 |
|
The Performance of Breast MRI Screening Among Women with BRCA1/2 Mutations
|
Mar 28, 2011 |
|
Circulating Tumor Cells in Resectable Colorectal Cancer
|
Mar 24, 2011 |
|
Results From a Phase I Trial of TG101348, a Selective JAK2 Inhibitor with Significant Activity in Symptomatic Myelofibrosis Patients
|
Mar 17, 2011 |
|
RIBBON-1 Revisited
|
Mar 17, 2011 |
|
Noninferiority of Denosumab As Compared With Zolendronic Acid With Respect to the Ability to Delay Skeletal Events in Patients With Solid Tumors and Multiple Myeloma
|
Mar 17, 2011 |